Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial

por Menter, Alan
Publicado 2023

Letter from the Editors

por Menter, Alan, Warren, Richard
Publicado 2011

A Summary of 2018 and What Lies Ahead for Dermatology and Therapy in 2019

por Menter, Alan, Warren, Richard
Publicado 2019

Dermatology: Future Therapeutic Perspectives

por Warren, Richard B., Menter, Alan
Publicado 2013

Erratum to: Letter from the Editors

por Menter, Alan, Warren, Richard B.
Publicado 2016

Psoriatic Arthritis: An Update

por Lloyd, Peter, Ryan, Caitriona, Menter, Alan
Publicado 2012

Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis

por Kivelevitch, Dario, Mansouri, Bobbak, Menter, Alan
Publicado 2014

Clinical utility of secukinumab in moderate-to-severe scalp psoriasis: evidence to date

por Kivelevitch, Dario, Amin, Sima, Menter, Alan
Publicado 2019

Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options

por Menter, Alan, Van Voorhees, Abby S., Hsu, Sylvia
Publicado 2021

A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis

por Campa, Molly, Mansouri, Bobbak, Warren, Richard, Menter, Alan
Publicado 2015

The Validity of Cutaneous Body Image as a Construct and as a Mediator of the Relationship Between Cutaneous Disease and Mental Health

por Hinkley, Sarah B., Holub, Shayla C., Menter, Alan
Publicado 2020

Emerging Therapies for the Treatment of Psoriasis

por Patel, Mahir, Day, Antoinette, Warren, Richard B., Menter, Alan
Publicado 2012

Erratum to: A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis

por Campa, Molly, Mansouri, Bobbak, Warren, Richard B., Menter, Alan
Publicado 2016

Topical dermal steroid–induced retinopathy

por Hilton, Taylor, DeCrescenzo, Andrew, Menter, Alan, Chavala, Sai H.
Publicado 2020

Calcipotriol/Betamethasone Dipropionate Cutaneous Foam Treatment for Psoriasis in Patients With BSA 5–15% and PGA ≥ 3: Post-Hoc Analysis From Three Randomized Controlled Trials...

por Iversen, Lars, Kurvits, Merle, Snel-Prentø, Anja Marieke, Menter, Alan
Publicado 2020

Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis

por Menter, Alan, Bhutani, Tina, Ehst, Benjamin, Elewski, Boni, Jacobson, Abby
Publicado 2022

Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics

por Menter, Alan, Armstrong, April, Van Voorhees, Abby, Liu, Clive, Jacobson, Abby
Publicado 2020

Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis

por Haugh, Isabel M, Preston, Allie K, Kivelevitch, Dario N, Menter, Alan M
Publicado 2018

Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies

por Menter, Alan, Cather, Jennifer C., Jarratt, Michael, Meng, Xiangyi, Guana, Adriana, Nyirady, Judit
Publicado 2016

Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence

por Wu, Jashin J., Merola, Joseph F., Feldman, Steven R., Menter, Alan, Lebwohl, Mark
Publicado 2020